Trial Profile
A comparison trial of dual therapy with vonoprazan and amoxicillin and standard PPI-based triple therapy with amoxicillin and clarithromycin or metronidazole in patients infected with H. pylori
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2016
Price :
$35
*
At a glance
- Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; Metronidazole (Primary) ; Vonoprazan (Primary)
- Indications Helicobacter pylori infections
- Focus Therapeutic Use
- 20 Apr 2016 New trial record
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics